Nu-Med Plus, Inc. (NUMD) stock
NUMDOTCGold and Silver OresFiscal year ends December 31
$0.01−0.00 (-8.16%)
Close on Oct 19, 2026Market cap $601.55KP/E –Yield –
Nu-Med Plus r&d expenses
Research and development expenses are spending on new products and technology.
For fiscal 2013 it was $66.21K, up 199.2% from the year before.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2013 | Dec 31, 2013 | $66.21K | +199.2% |
| FY2012 | Dec 31, 2012 | $22.13K | – |
See a number that looks wrong?